Ivan Ozerov PhD

Dr. Ivan Ozerov is Director, Drug Discovery, Aging and Age-related diseases, at Insilico Medicine, a Baltimore-based leader in the next-generation artificial intelligence and blockchain technologies for drug discovery, biomarker development, and aging research. Ivan graduated from Lomonosov Moscow State University in 2010 and defended his Ph.D. in radiobiology in 2015.

Ivan’s Ph.D. thesis was related to kinetic modeling of the cellular pathways affected by exposure to ionizing radiation and cellular senescence. Ivan joined the international team of Insilico Medicine, Inc. in 2015 through winning the bioinformatics hackathon in Russia. Since 2015 Ivan has developed the novel state-of-the-art tool for 'omics data analysis on the level of cellular signalling pathways (iPANDA). The team led by Ivan has successfully developed and launched Young.AI, an AI-empowered platform integrating multiple biomarkers of human age in order to manage personal health, track changes overtime and optimize people's lifestyles.